9.50
0.22 (2.37%)
| Previous Close | 9.28 |
| Open | 9.60 |
| Volume | 59,889 |
| Avg. Volume (3M) | 22,882 |
| Market Cap | 47,734,176 |
| Price / Book | 0.430 |
| 52 Weeks Range | |
| Earnings Date | 13 Mar 2025 - 17 Mar 2025 |
| Diluted EPS (TTM) | -11.73 |
| Total Debt/Equity (MRQ) | 7.48% |
| Current Ratio (MRQ) | 22.63 |
| Operating Cash Flow (TTM) | -67.70 M |
| Levered Free Cash Flow (TTM) | -17.10 M |
| Return on Assets (TTM) | -22.33% |
| Return on Equity (TTM) | -45.37% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | AlloVir, Inc. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | 0.0 |
| Average | -0.67 |
|
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 34.46% |
| % Held by Institutions | 50.64% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |